Global to push GA events into
skip to main content

Title: Nuclear magnetic resonance contrast agents

A family of contrast agents for use in magnetic resonance imaging and a method of enhancing the contrast of magnetic resonance images of an object by incorporating a contrast agent of this invention into the object prior to forming the images or during formation of the images. A contrast agent of this invention is a paramagnetic lanthanide hexaazamacrocyclic molecule, where a basic example has the formula LnC.sub.16 H.sub.14 N.sub.6. Important applications of the invention are in medical diagnosis, treatment, and research, where images of portions of a human body are formed by means of magnetic resonance techniques.
 [1];  [1];  [1];  [1]
  1. (Los Alamos, NM)
Issue Date:
OSTI Identifier:
United States of America as represented by United States (Washington, DC) LANL
Patent Number(s):
US 5702683
Contract Number:
Research Org:
Los Alamos National Laboratory (LANL), Los Alamos, NM
Country of Publication:
United States
nuclear; magnetic; resonance; contrast; agents; family; imaging; method; enhancing; images; incorporating; agent; prior; forming; formation; paramagnetic; lanthanide; hexaazamacrocyclic; molecule; basic; example; formula; lnc; 16; 14; applications; medical; diagnosis; treatment; portions; human; formed; means; techniques; resonance imaging; magnetic resonance; nuclear magnetic; resonance techniques; medical diagnosis; contrast agents; contrast agent; /424/436/999/